Silvano Cominelli

Director Ejecutivo en

GianCom AG

59 años

19 relaciones

Health Technology

Finance

Consumer Services

Perfil

Silvano Cominelli is currently Chief Executive Officer & Chief Investment Officer at GianCom AG since 2017.
Formerly, Dr. Cominelli was Director at Broncus Technologies, Inc. from 2007 to 2013, Director at Pelikan Technologies, Inc., Director-Neurology Business Unit at Serono SA from 1998 to 2000, and Investment Advisor at HBM Partners AG (Investment Management).
Dr. Cominelli earned a doctorate from the University of Zurich in 1999.

Cargos activos de Silvano Cominelli

Empresas	Cargo	Inicio
GianCom AG GianCom AG Investment ManagersFinance GianCom specializes in global equity investments, predominantly in growth sectors and compounders in the industries health care, technology, consumer and industrials with a focus on developed countries. The firm incorporates a fundamental, bottom-up stock picking process. Investment decisions are based on in-depth fundamental research into a company’s financial and business strengths/weaknesses, its growth prospect and unique industry positioning as well as the quality of management and capital returns.	Director Ejecutivo	20/09/2017

Todos los cargos activos de Silvano Cominelli

Antiguos cargos conocidos de Silvano Cominelli.

Empresas	Cargo	Fin
Broncus Technologies, Inc. Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Develops solutions for diagnosing and treating lung diseases	Director/Miembro de la Junta	01/02/2013
Serono SA Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs	Corporate Officer/Principal	01/12/2000
HBM Partners AG (Investment Management) HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs.	Analyst-Equity	-
Pelikan Technologies, Inc. Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Develops hand held diagnostic and monitoring devices	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Silvano Cominelli.

Formación de Silvano Cominelli.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Silvano Cominelli.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	6
Broncus Technologies, Inc. Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Develops solutions for diagnosing and treating lung diseases	Health Technology
Pelikan Technologies, Inc. Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Develops hand held diagnostic and monitoring devices	Health Technology
Serono SA Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs	Health Technology
University of Zurich University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
HBM Partners AG (Investment Management) HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs.	Finance
GianCom AG GianCom AG Investment ManagersFinance GianCom specializes in global equity investments, predominantly in growth sectors and compounders in the industries health care, technology, consumer and industrials with a focus on developed countries. The firm incorporates a fundamental, bottom-up stock picking process. Investment decisions are based on in-depth fundamental research into a company’s financial and business strengths/weaknesses, its growth prospect and unique industry positioning as well as the quality of management and capital returns.	Finance